Prograf
These highlights do not include all the information needed to use PROGRAF safely and effectively. See full prescribing information for PROGRAF. PROGRAF (tacrolimus) capsules, for oral usePROGRAF (tacrolimus) injection, for intravenous usePROGRAF Granules (tacrolimus for oral suspension)Initial U.S. Approval: 1994
7f667de1-9dfa-4bd6-8ba0-15ee2d78873b
HUMAN PRESCRIPTION DRUG LABEL
Aug 25, 2023
Astellas Pharma US, Inc.
DUNS: 605764828
Products 6
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Tacrolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
Tacrolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (3)
Tacrolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (4)
Tacrolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
Tacrolimus
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (1)
Tacrolimus
Product Details
FDA regulatory identification and product classification information